Oxeltis will be present at the 37th ACS National Medicinal Chemistry Symposium in NY June 26-29th. We are very happy to meet you soon, come and visit our poster booth#1 (...)
Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large B-cell lymphoma Oss, the Netherlands and Montpellier, France, June 8, 2022 – Lead Pharma, a (...)